King Pharmaceuticals KG GLS — Number of remaining retroactive reinsurance contracts

Similar metrics at other companies

ORIGeneral Liability — All outstanding liabilities before 2016, net of reinsurance

$176.1M-3.0%

MKLGlobal Reinsurance Division — All outstanding liabilities for unpaid losses and loss adjustment expenses before 2016, net of reinsurance

$295.7M—

AXSReinsurance — Gross outstanding liabilities

$8.88B+29.2%

BHFULSG — Additional Liability, Long-Duration Insurance, after Reinsurance

$8.4B+10.2%

BHFULSG — Additional Liability, Long-Duration Insurance, Reinsurance Recoverable, after Allowance

$1.82B+17.2%

AXSReinsurance — All outstanding liabilities before 2016, net of reinsurance

$565.17M+1,364%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept kg:NumberOfRemainingRetroactiveReinsuranceAgreements.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's gls — number of remaining retroactive reinsurance contracts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's GLS — number of remaining retroactive reinsurance contracts?: King Pharmaceuticals (KG) reported GLS — number of remaining retroactive reinsurance contracts of 0.5 in Q4 2025.
What does GLS — number of remaining retroactive reinsurance contracts mean?: This metric tracks the count of active retroactive reinsurance contracts held by the segment. These agreements provide coverage for losses occurring before the contract inception date, often used to manage legacy liabilities. A declining number indicates a reduction in exposure to historical loss volatility and a cleaner balance sheet.